investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Development of TGF-beta antagonists for cancer therapy
Lalage Wakefield
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Peter Watson
BC Cancer Agency
Vancouver, Canada
Lalage Wakefield
National Cancer Institute (NIH)
Rockville, United States
Related projects
Kinam Park
Adaptable Polymer Micelles for Tumor Targeting
Breast
Carol Prives
Roles and Regulation of p53
Breast
Maxwell Lee
Genetics and Epigenetics of Cancer
Breast
Rachelle W Johnson
Characterization of breast cancer dormancy in bone
Breast
Marcus E Peter
Fas protects cancer stem cells from death
Breast
Kuo-Hsiung Lee
Novel Antitumor Agents
Breast
Calvin J Kuo
miR-126 Regulation of Tumor Progression
Breast
Julie Secombe
Distinct Modes of Gene Regulation by KDM5
Breast
Lisa M Coussens
Regulating the Immune Microenvironment in Breast Cancer
Breast
